Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?

Objective: Platelet aggregation tests and the analysis of thromboxane A2 metabolites [serum thromboxane B2 (TXB2) and urine 11-dehydro TXB2] are used to evaluate the efficacy of aspirin. In myeloproliferative neoplasms (MPNs), the immature platelet fraction (IPF) rises due to enhanced platelet turno...

Full description

Bibliographic Details
Main Authors: Ilgın Koçak Göktürk, Işıl Erdoğan Özünal, Alican Göktürk, Ali Hakan Kaya, Güven Yılmaz, Olga Meltem Akay, Erman Öztürk
Format: Article
Language:English
Published: Galenos Publishing House 2023-03-01
Series:Turkish Journal of Hematology
Subjects:
thromboxane b2
platelet aggregation
platelets
arachidonic acid
aspirin
Online Access:https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-90008

Internet

https://tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-90008

Similar Items